About LifeEDIT
LifeEDIT is a company based in Durham (United States) founded in 2017 was acquired by ElevateBio in October 2021. LifeEDIT offers products and services including Gene Editing Platform and RNA-Guided Nucleases Library. LifeEDIT operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Durham, United States
- SectorsHealthcare
- Website lifeeditinc.com
- Social LinkedIn X
- Acquired by ElevateBio (Oct 2021)
- Legal Name Life Edit Therapeutics
- Investors
- Acquired byElevateBio
(Oct 2021)
Products & Services of LifeEDIT
LifeEDIT offers a comprehensive portfolio of products and services, including Gene Editing Platform and RNA-Guided Nucleases Library.
Enables targeted genomic edits for developing genetic disease therapies.
Provides diverse nucleases for precise DNA modifications in research.
Investors in LifeEDIT
LifeEDIT has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ElevateBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of transnational research for portfolio of cell and gene therapy | 2018 | elevate.bio | Cambridge, United States |
Investor details for LifeEDIT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LifeEDIT
60 people are tracked at LifeEDIT (20 in leadership, 40 in team).
| Name | Role | Group |
|---|---|---|
Joel Parker | Vice President | Leadership |
David Hallal | Chairman & Chief Executive Officer, Elevatebio | Leadership |
Missy Kotchey | Vp, Head Of People | Leadership |
Tedd Elich | Chief Scientific Officer | Leadership |
Bhakti Bhargava | Senior Vp, Head Of Finance & Accounting | Leadership |
Drew Kelso | Associate Director | Leadership |
Hélène Svahnqvist | Vice President | Leadership |
Sarah Compton | Associate Director | Leadership |
Hung Nguyen | Associate Director | Leadership |
Adrian Pickar Oliver | Associate Director Of Technology Development | Leadership |
K. Tyler McCullough | Associate Director | Leadership |
Adrian Oliver | Associate Director | Leadership |
April Sena | Vice President Technical Operations | Leadership |
Michael Coyle | Director | Leadership |
John Russell | Director Lab Automation | Leadership |
Chunhua Qin | Associate Director | Leadership |
Vlad Kuznetsov | Associate Director | Leadership |
Chase Brett | Associate Director | Leadership |
Shaorong Chong | Vice President Of Crispr Technology Development | Leadership |
David Wiley | Associate Director | Leadership |
40 more people are available in the full profile.
Complete people profiles for LifeEDIT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LifeEDIT
2 dated milestones of LifeEDIT across 4 years, from founding to its latest funding, stage changes and deals.
- Founded LifeEDIT is founded.
- Exit Acquired by ElevateBio.
Competitors of LifeEDIT
LifeEDIT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of LifeEDIT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LifeEDIT
Websites that share an audience with LifeEDIT (lifeeditinc.com).
Websites whose visitors overlap most with LifeEDIT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| catawbaresearch.com | 100% | 3.5K | #5,071,999 | View details | |
| altisbiosystems.com | 100% | 16.6K | #1,779,798 | View details | |
| xilis.com | 85% | 2.5K | #6,836,474 | View details | |
| saperebio.com | 82% | – | – | View details |
Latest news on Lifeedit
Complete news archive for LifeEDIT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to LifeEDIT
10 companies that operate in the same segment as LifeEDIT (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LifeEDIT
LifeEDIT was founded in 2017.
LifeEDIT is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
LifeEdit was founded in 2017 and is based in Durham, United States, within the biotechnology sector. A genome editing platform featuring RNA-guided nucleases active in mammalian cells is utilized to develop therapeutics focused on neuroscience, immuno-oncology, and stem cells. Technologies for agriculture are also advanced, targeting agronomic traits, quality improvements, and accelerated breeding processes.
LifeEDIT's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
LifeEDIT offers Gene Editing Platform and RNA-Guided Nucleases Library.
LifeEDIT has 1 investor. Key investors include ElevateBio.
LifeEDIT operates through Life Edit Therapeutics.
Yes. LifeEDIT was acquired by ElevateBio in October 2021.